Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Läkare Engfeldt AB
AB
Active
Org 5591646939
Stavshällsvägen 12
General medical practice activities · NACE 8621
Est. 2018
3 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 944K
+2046% vs 2024
EBITDA margin
62.7%
+1685% vs 2024
Equity ratio
59.0%
Financial strength
Net profit 2025
SEK 470K
+483% vs 2024
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
0M
2022
0M
0%
2023
0M
0%
2023
0M
0%
2024
1M
+100%
2025
Key figures
Annual report 2025
Revenue
SEK 944K
+2046%
EBITDA
SEK 592K
+1685%
Net profit
SEK 470K
+483%
Total assets
SEK 890K
+485%
Equity
SEK 525K
+288%
Employees
3
—
Company information
Legal name
Läkare Engfeldt AB
Org number
5591646939
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 juli 2018
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom allmänmedicin och därmed förenlig verksamhet samt kapital och fastighetsförvaltning.
Contact
Address
Stavshällsvägen 12
Email
ted.engfeldt@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2023
0M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2023
0M
2024
1M
2025
Income statement
SEK thousands
Item
2022
2023
2023
2024
2025
Revenue
0
50
419
44
944
Staff expenses
−0
—
−66
−2
−244
EBITDA
−7
42
322
33
592
Depreciation & amort.
—
—
—
—
—
EBIT
−7
42
322
33
592
Net financials
—
0
2
4
0
Profit before tax
80
42
259
102
592
Tax
−17
−9
−53
−21
−122
Net profit
63
33
205
81
470
Balance sheet
SEK thousands
Item
2022
2023
2023
2024
2025
Total assets
189
143
513
152
890
Equity
166
99
305
135
525
Long-term debt
—
—
—
—
0
Short-term debt
22
44
144
17
365
Total debt
22
44
144
17
365
Financial ratios
5-year trend
EBITDA margin
62.7%
This company
15.8%
Market median
+297% vs market
2022
2025
Equity ratio
59.0%
This company
38.2%
Market median
+54% vs market
2022
2025
Return on equity
89.5%
This company
18.4%
Market median
+386% vs market
2022
2025
Net profit margin
49.8%
This company
8.1%
Market median
+515% vs market
2022
2025
Asset turnover
1.06×
This company
1.12×
Market median
+5% vs market
2022
2025
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2023-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
AS
Anna Sara Ingrid Heléne Engfeldt
Deputy Board Member
2022
TZ
Ted Zygmunt Engfeldt
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Läkare Engfeldt AB also hold positions in
0
other companies.
Person
Role here
Other companies
Anna Sara Ingrid Heléne Engfeldt
Deputy Board Member
0 companies
Ted Zygmunt Engfeldt
Board of Directors
0 companies